Join
Live feed
·
INSIDERFilingvia Quantisnow
Rani Therapeutics Holdings Inc. logo

Nanavaty Maulik bought $990 worth of shares (500 units at $1.98) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RANI· Rani Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RANI (Rani Therapeutics Holdings Inc.) and more on Quantisnow.